PHARMACEUTICAL COMPOSITION COMPRISING PISTACIA WEINMANNIFOLIA EXTRACT, FRACTION OF SAME OR COMPOUND SEPARATED FROM SAME FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

• Main Authors: AHN, Kyung Seop, KIM, Seung Hyung, KIM, Jung Hee, LI, Wan Yi, OH, Sei Ryang, RYU, Hyung Won, JIN, Hang, LEE, Sang Woo, LEE, Joong Ku, SHIN, In Sik, CHOI, Sang Ho
• Format: Patent
• Language: English; French; German
• Published: 22.02.2017
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

The present invention relates to a composition for suppressing chronic obstructive pulmonary disease (COPD) comprising a Pistacia weinmannifolia extract, a fraction thereof, or a compound isolated therefrom and, more particularly, to a pharmaceutical composition for preventing or treating COPD comprising a Pistacia weinmannifolia extract, a fraction thereof, or a compound isolated therefrom; a food composition for preventing or improving COPD, and the compound isolated therefrom. The composition comprising a Pistacia weinmannifolia extract, a fraction thereof, or a compound isolated therefrom, according to the present invention, is not toxic, suppresses the invasion of inflammatory cells into the bronchial tube of a COPD-induced animal model, and effectively suppresses the expression of CXCL-1, TNF-±, or MIP-2. In addition, due to the use of a safety-proven herbal drug as a raw material, the composition of the present invention can resolve various side-effects of existing therapeutic agents for COPD, chronic obstructive bronchitis, chronic bronchiolitis, emphysema, multiple sclerosis, and acute and chronic inflammation, and thus can be effectively used as a composition for preventing, treating and remedying COPD.